Pancreatic Cancer Research

ResearcherBeijing University of TechnologyNo recent work listed

Aamir Ali Khan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1193-8806; OpenAlex author ID A5048095777. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 4 papers

Papers 6

  1. L3MBTL2-mediated CGA transcriptional suppression promotes pancreatic cancer progression through modulating autophagy. Co-author DOI 10.1016/j.isci.2022.104249↗
  2. Ribosome 18S m6A methyltransferase METTL5 promotes pancreatic cancer progression by modulating c‑Myc translation. Co-author DOI 10.3892/ijo.2021.5299↗
  3. WBSCR22 and TRMT112 synergistically suppress cell proliferation, invasion and tumorigenesis in pancreatic cancer via transcriptional regulation of ISG15. Co-author DOI 10.3892/ijo.2022.5314↗
  4. TSPAN1-elevated FAM110A promotes pancreatic cancer progression by transcriptionally regulating HIST1H2BK. Co-author DOI 10.7150/jca.66404↗
  5. An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression. Co-author DOI 10.1007/s10555-020-09952-0↗
  6. miR-216a-mediated upregulation of TSPAN1 contributes to pancreatic cancer progression via transcriptional regulation of ITGA2. Co-author PMID 32368389↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xinhui Liu · 6 shared papers, 2020–2022 · strength 0.94
  2. Hua Huang · 6 shared papers, 2020–2022 · strength 0.94
  3. Shensen Wang · 2 shared papers, 2020–2022 · strength 0.28
  4. Ting Zhao · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.